4//SEC Filing
ZIOPHARM ONCOLOGY INC 4
Accession 0001209191-15-000204
$TCRTCIK 0001107421operating
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:08 PM ET
Size
7.2 KB
Accession
0001209191-15-000204
Insider Transaction Report
Form 4
BELBEL CAESAR J
EVP, Chief Legal Officer & Sec
Transactions
- Award
Employee Stock Option (Right to Buy)
2014-12-31+175,000→ 175,000 totalExercise: $5.07Exp: 2024-12-30→ Common Stock (175,000 underlying) - Tax Payment
Common Stock
2014-12-30$5.03/sh−7,192$36,176→ 23,802 total
Footnotes (2)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- [F2]58,334 shares shall vest on 12/31/2015; 58,333 shares shall vest on each of 12/31/2016 and 12/31/2017.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001107421
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:08 PM ET
- Size
- 7.2 KB